First Step Recovery Center
First Step Recovery Center was paid $406K by Medicaid between Feb 2018 and Jul 2022, across 37 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 12% of everything it billed.
LANCASTER, OH 43130
Next to other Clinical Medical Laboratory providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,004 | $108K | |
| 2019 | 10,136 | $126K | |
| 2020 | 6,333 | $80K | |
| 2021 | 417 | $51K | |
| 2022 | 501 | $41K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 12% | 337 | 292 | $50K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.2% | 960 | 644 | $37K |
| 80362 | 9.1% | 2,300 | 1,702 | $37K | |
| 80346 | 6.4% | 1,203 | 987 | $26K | |
| 80348 | 6.0% | 2,432 | 1,790 | $24K | |
| 83992 | 4.2% | 1,286 | 1,044 | $17K | |
| 80361 | 4.1% | 914 | 771 | $17K | |
| 80349 | 4.0% | 1,575 | 1,274 | $16K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 3.9% | 134 | 98 | $16K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3.7% | 174 | 161 | $15K |
| 80353 | 3.5% | 1,403 | 1,121 | $14K | |
| 80356 | 3.4% | 1,366 | 1,098 | $14K |
25 more codes
| 80359 | 3.3% | 1,301 | $13K | |
| 80324 | 3.0% | 1,173 | $12K | |
| 80360 | 2.7% | 1,090 | $11K | |
| 80345 | 2.7% | 1,073 | $11K | |
| 80355 | 2.5% | 1,020 | $10K | |
| 80370 | 2.4% | 914 | $10K | |
| 80365 | 1.9% | 777 | $8K | |
| 80354 | 1.9% | 744 | $8K | |
| 80358 | 1.7% | 678 | $7K | |
| 80373 | 1.7% | 666 | $7K | |
| 80372 | 1.7% | 662 | $7K | |
| 80366 | 1.3% | 570 | $5K | |
| 80363 | <1% | 173 | $3K | |
| 80323 | <1% | 221 | $2K | |
| 80368 | <1% | 147 | $1K | |
| 80321 | <1% | 131 | $1K | |
| 80371 | <1% | 138 | $1K | |
| 80332 | <1% | 117 | $1K | |
| 80338 | <1% | 103 | $884.05 | |
| 80369 | <1% | 98 | $839.85 | |
| 80342 | <1% | 97 | $831.01 | |
| 80335 | <1% | 97 | $831.01 | |
| 80325 | <1% | 70 | $627.68 | |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | <1% | 69 | $144.80 |
| 81002 | <1% | 178 | $13.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Monarch Health and Recovery LLC | West Portsmouth, OH | $7.50M |
| Southwestern Recovery Center, LLC | Grove City, OH | $5.47M |
| Reach for Tomorrow INC | Greenfield, OH | $4.00M |
| Memorial Hermann Health System | Houston, TX | $3.31M |
| Blue Jackets Braces | Delaware, OH | $916K |
| Southwestern Recovery Center, LLC | Columbus, OH | $657K |
| Addiction Angels of America, LLC | Columbus, OH | $521K |
| First Step Recovery Center | Reynoldsburg, OH | $264K |
| Quest Recovery Center, LLC | Mount Vernon, OH | $181K |
| Moon Family & Behavioral Health LLC | Pickerington, OH | $144K |
| Reach for Tomorrow INC | Greenfield, OH | $106K |
| Southwestern Recovery Center, LLC | Grove City, OH | $53K |
| Southwestern Recovery Center, LLC | Columbus, OH | $49K |
| Pain Evaluation and Management Center of Ohio, INC. | Washington Township, OH | $44K |
| Cardinal Treatment Centers INC | Portsmouth, OH | $38K |
| Monarch Health and Recovery LLC | West Portsmouth, OH | $27K |
| Columbus Obstetric and Gynecology Center | Columbus, OH | $22K |
| Cornerstone Project | Dayton, OH | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.